1. Home
  2. SKIL vs RLYB Comparison

SKIL vs RLYB Comparison

Compare SKIL & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Skillsoft Corp.

SKIL

Skillsoft Corp.

HOLD

Current Price

$3.71

Market Cap

32.5M

Sector

Technology

ML Signal

HOLD

Logo Rallybio Corporation

RLYB

Rallybio Corporation

HOLD

Current Price

$9.50

Market Cap

28.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SKIL
RLYB
Founded
1998
2018
Country
United States
United States
Employees
2261
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.5M
28.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SKIL
RLYB
Price
$3.71
$9.50
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
N/A
AVG Volume (30 Days)
148.0K
243.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
27.72
EPS
N/A
N/A
Revenue
N/A
$600,000.00
Revenue This Year
N/A
$17.61
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.72
$0.22
52 Week High
$23.00
$11.49

Technical Indicators

Market Signals
Indicator
SKIL
RLYB
Relative Strength Index (RSI) 31.34 71.26
Support Level $3.72 $0.48
Resistance Level $4.84 $11.49
Average True Range (ATR) 0.47 0.89
MACD 0.08 -0.09
Stochastic Oscillator 0.45 68.17

Price Performance

Historical Comparison
SKIL
RLYB

About SKIL Skillsoft Corp.

Skillsoft Corp is a leader in corporate digital learning. The company's segments include Talent Development Solutions and Global Knowledge. Talent Development Solutions brings a foundation of products and customers. TDS enterprise-grade solution serves customers and employees world-wide. TDS Learner is a world-renowned consumer-scale and experiential learning platform that serves learners internationally. The Global Knowledge segment is centered around instructor-led training, or live learning, with face-to-face delivery by experienced trainers, both in-person and virtually.

About RLYB Rallybio Corporation

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

Share on Social Networks: